Molecular epidemiological analysis of prostate cancer in Hunan population and research on the intervention of warming the kidney and promoting blood circulation and detoxification

the First Affiliated Hospital of Hunan University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Patients with undetermined or unknown prostate dynamic tumors requiring prostate needle biopsy. ? Suspicious prostate nodules on digital rectal examination, any prostate-specific antigen values; ? Transrectal prostate ultrasound or MRI found suspicious lesions with normal prostate-specific antigen; ? Prostate specific antigen > 10 ng/ mL; ? Prostate-specific antigen was 4-10 ng/ mL, and free prostate-specific antigen/total free prostate-specific antibody (fPSA/tPSA) was suspicious. Patients in line with the first two criteria should undergo prostate puncture biopsy regardless of the value of psa.

•? Patients who have been diagnosed with prostate cancer; ? Patients with serious heart, brain, liver and kidney diseases and intolerance to prostate biopsy; ? Those who are unwilling to receive needle biopsy of prostate.

发起方

the First Affiliated Hospital of Hunan University of Chinese Medicine